4-76555619-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_020859.4(SHROOM3):c.179G>T(p.Gly60Val) variant causes a missense change. The variant allele was found at a frequency of 0.00208 in 1,613,742 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0021 ( 4 hom. )
Consequence
SHROOM3
NM_020859.4 missense
NM_020859.4 missense
Scores
6
8
5
Clinical Significance
Conservation
PhyloP100: 6.34
Genes affected
SHROOM3 (HGNC:30422): (shroom family member 3) This gene encodes a PDZ-domain-containing protein that belongs to a family of Shroom-related proteins. This protein may be involved in regulating cell shape in certain tissues. A similar protein in mice is required for proper neurulation. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.045105994).
BP6
Variant 4-76555619-G-T is Benign according to our data. Variant chr4-76555619-G-T is described in ClinVar as [Benign]. Clinvar id is 1686322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHROOM3 | NM_020859.4 | c.179G>T | p.Gly60Val | missense_variant | 2/11 | ENST00000296043.7 | NP_065910.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHROOM3 | ENST00000296043.7 | c.179G>T | p.Gly60Val | missense_variant | 2/11 | 1 | NM_020859.4 | ENSP00000296043 | P1 | |
SHROOM3 | ENST00000466541.1 | n.86G>T | non_coding_transcript_exon_variant | 2/3 | 3 | |||||
SHROOM3 | ENST00000469923.5 | n.6G>T | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
SHROOM3 | ENST00000497440.5 | n.120G>T | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00154 AC: 234AN: 152198Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
234
AN:
152198
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00203 AC: 509AN: 251326Hom.: 0 AF XY: 0.00208 AC XY: 283AN XY: 135848
GnomAD3 exomes
AF:
AC:
509
AN:
251326
Hom.:
AF XY:
AC XY:
283
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00214 AC: 3123AN: 1461426Hom.: 4 Cov.: 32 AF XY: 0.00218 AC XY: 1588AN XY: 726986
GnomAD4 exome
AF:
AC:
3123
AN:
1461426
Hom.:
Cov.:
32
AF XY:
AC XY:
1588
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00154 AC: 234AN: 152316Hom.: 0 Cov.: 31 AF XY: 0.00134 AC XY: 100AN XY: 74474
GnomAD4 genome
AF:
AC:
234
AN:
152316
Hom.:
Cov.:
31
AF XY:
AC XY:
100
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
12
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
33
ExAC
AF:
AC:
245
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
SHROOM3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at